Clinical Trials Directory

Trials / Unknown

UnknownNCT05764434

ALS Spinal Cord Gray and White Matter Study

Spinal Cord Gray and White Matter Imaging in Amyotrophic Lateral Sclerosis

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This study aims to measure in vivo the spinal cord gray and white matter in patients with Amyotrophic Lateral Sclerosis and healthy persons that match the patients' age and sex using rAMIRA imaging, a novel Magnetic Resonance Imaging (MRI) method. Patients and healthy control persons prospectively undergo MRI examinations, clinical examinations including assessments of disability, and tests of muscle force using hand held dynamometry. Serum markers of neuro-axonal injury are also assessed. Examinations for patients and healthy control persons are scheduled every six months over a time span of two years.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic Resonance ImagingMagnetic Resonance Imaging of the spinal cord using radially acquired Averaged Magnetization Inversion Recovery Acquisitions (rAMIRA)

Timeline

Start date
2018-05-01
Primary completion
2025-05-01
Completion
2025-10-01
First posted
2023-03-10
Last updated
2023-11-14

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05764434. Inclusion in this directory is not an endorsement.

ALS Spinal Cord Gray and White Matter Study (NCT05764434) · Clinical Trials Directory